Polyubiquitination inhibition of estrogen receptor alpha and its implications in breast cancer

doi:10.5306/wjco.v9.i4.60

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 9, Issue 4

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (10779)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-4) series.

Item

Count

PDF

662

WORD

250

HTML

6046

Figures (1-4)

353

Sum=7311

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

485

Download

890

Sum=1375

Publishing Process of This Article

Item

Count

Browse

801

Download

1292

Sum=2093

Aug 13, 2018 (publication date) through Jul 23, 2024

Times Cited of This Article

Times Cited (14)

Journal Information of This Article

Publication Name

World Journal of Clinical Oncology

ISSN

2218-4333

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Clin Oncol. Aug 13, 2018; 9(4): 60-70
Published online Aug 13, 2018. doi: 10.5306/wjco.v9.i4.60

Full Size Figure Download Figure

Figure 3 Mucin 1 is an estrogen receptor α polyubiquitination inhibitor protein in breast cancer cells.

Citation: Tecalco-Cruz AC, Ramírez-Jarquín JO. Polyubiquitination inhibition of estrogen receptor alpha and its implications in breast cancer. World J Clin Oncol 2018; 9(4): 60-70
URL: https://www.wjgnet.com/2218-4333/full/v9/i4/60.htm
DOI: https://dx.doi.org/10.5306/wjco.v9.i4.60